Files and links (1)
Published, Version of Record (VoR)Open Access (License Unspecified), Open
Journal article
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis
Antimicrobial agents and chemotherapy, v 32(2), pp 262-264
Feb 1988
PMID: 3163241
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
This study compared difloxacin administered orally, enoxacin administered orally, and cefazolin administered intramuscularly for the treatment of experimental Staphylococcus aureus endocarditis. Difloxacin significantly reduced bacterial counts of vegetations compared with enoxacin. This study demonstrated that difloxacin was significantly more effective than enoxacin and as effective as cefazolin for the treatment of S. aureus endocarditis in rabbits.
Metrics
Details
- Title
- Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis
- Creators
- J A Boscia - Drexel UniversityW D Kobasa - Drexel UniversityD Kaye - Drexel University
- Publication Details
- Antimicrobial agents and chemotherapy, v 32(2), pp 262-264
- Publisher
- American Society for Microbiology (ASM)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:A1988M007200022
- Scopus ID
- 2-s2.0-0023930827
- Other Identifier
- 991019183970104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Microbiology
- Pharmacology & Pharmacy